Agilent Technologies (NYSE:A) Releases FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 5.540-5.610 for the period, compared to the consensus earnings per share estimate of 5.570. The company issued revenue guidance of $6.7 billion-$6.8 billion, compared to the consensus revenue estimate of $6.8 billion. Agilent Technologies also updated its Q2 2025 guidance to 1.250-1.280 EPS.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Bank of America decreased their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a report on Monday, December 9th. Citigroup raised their target price on Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, JPMorgan Chase & Co. lowered their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $144.38.

Agilent Technologies Stock Performance

NYSE:A traded up $0.33 during trading hours on Wednesday, hitting $134.51. 1,538,129 shares of the company traded hands, compared to its average volume of 1,675,135. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $38.37 billion, a price-to-earnings ratio of 30.43, a P/E/G ratio of 3.66 and a beta of 1.07. The firm has a 50-day moving average of $140.87 and a 200 day moving average of $139.31. Agilent Technologies has a twelve month low of $124.16 and a twelve month high of $155.35.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. On average, analysts forecast that Agilent Technologies will post 5.56 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is presently 22.40%.

Insider Activity at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.